BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16724423)

  • 1. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study.
    Osterlund A; Kahlmeter G; Haeggman S; Olsson-Liljequist B;
    Scand J Infect Dis; 2006; 38(5):334-4. PubMed ID: 16724423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid.
    Osterlund A; Eden T; Olsson-Liljequist B; Haeggman S; Kahlmeter G;
    Scand J Infect Dis; 2002; 34(10):729-34. PubMed ID: 12477322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics.
    Rørtveit S; Skutlaberg DH; Langeland N; Rortveit G
    J Antimicrob Chemother; 2011 Jun; 66(6):1360-4. PubMed ID: 21393202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area.
    El-Zimaity D; Kearns AM; Dawson SJ; Price S; Harrison GA
    J Antimicrob Chemother; 2004 Aug; 54(2):441-6. PubMed ID: 15269197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.
    O'Neill AJ; Larsen AR; Henriksen AS; Chopra I
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3594-7. PubMed ID: 15328136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.
    Rijnders MI; Wolffs PF; Hopstaken RM; den Heyer M; Bruggeman CA; Stobberingh EE
    J Antimicrob Chemother; 2012 May; 67(5):1176-80. PubMed ID: 22290345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
    Yu F; Liu Y; Lu C; Lv J; Qi X; Ding Y; Li D; Huang X; Hu L; Wang L
    BMC Microbiol; 2015 Oct; 15():210. PubMed ID: 26463589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of a Staphylococcus aureus Clone Resistant to Mupirocin and Fusidic Acid Carrying Exotoxin Genes and Causing Mainly Skin Infections.
    Doudoulakakis A; Spiliopoulou I; Spyridis N; Giormezis N; Kopsidas J; Militsopoulou M; Lebessi E; Tsolia M
    J Clin Microbiol; 2017 Aug; 55(8):2529-2537. PubMed ID: 28592549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
    Howden BP; Grayson ML
    Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients.
    Edslev SM; Clausen ML; Agner T; Stegger M; Andersen PS
    J Antimicrob Chemother; 2018 Apr; 73(4):856-861. PubMed ID: 29253168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis.
    Alsterholm M; Flytström I; Bergbrant IM; Faergemann J
    Acta Derm Venereol; 2010; 90(1):52-7. PubMed ID: 20107726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
    Rennie RP
    J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains.
    Chang SC; Hsieh SM; Chen ML; Sheng WH; Chen YC
    Diagn Microbiol Infect Dis; 2000 Feb; 36(2):131-6. PubMed ID: 10705056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing.
    Mason BW; Howard AJ; Magee JT
    J Antimicrob Chemother; 2003 Apr; 51(4):1033-6. PubMed ID: 12654748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An epidemic of bullous impetigo in the municipality of Austevoll in the year 2002].
    Rørtveit S; Rørtveit G
    Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2557-60. PubMed ID: 14714041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual outbreak in the Netherlands: community-onset impetigo caused by a meticillin-resistant
    Vendrik KEW; Kuijper EJ; Dimmendaal M; Silvis W; Denie-Verhaegh E; de Boer A; Postma B; Schoffelen AF; Ruijs WLM; Koene FMHPA; Petrignani M; Hooiveld M; Witteveen S; Schouls LM; Notermans DW;
    Euro Surveill; 2022 Dec; 27(49):. PubMed ID: 36695440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France.
    Laurent F; Tristan A; Croze M; Bes M; Meugnier H; Lina G; Vandenesch F; Etienne J
    J Antimicrob Chemother; 2009 Feb; 63(2):420-1; author reply 421. PubMed ID: 18978362
    [No Abstract]   [Full Text] [Related]  

  • 18. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
    Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
    Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections.
    Liu Y; Geng W; Yang Y; Wang C; Zheng Y; Shang Y; Wu D; Li X; Wang L; Yu S; Yao K; Shen X
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):212-8. PubMed ID: 22066960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK.
    Ravenscroft JC; Layton A; Barnham M
    Clin Exp Dermatol; 2000 Jun; 25(4):327-30. PubMed ID: 10971497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.